In conclusion, our study is the first to demonstrate that PLOD1, PLOD2, and PLOD3 mRNA and protein expression is elevated in ccRCC compared with normal kidney, and that high PLOD1/2/3 mRNA levels predict poor prognosis. This evidence concerns the gene PLOD2 and nonpapillary renal cell carcinoma.